Madrigal Pharmaceuticals, Inc. (MDGL)
NASDAQ: MDGL · Real-Time Price · USD
516.69
-3.40 (-0.65%)
At close: Apr 28, 2026, 4:00 PM EDT
517.50
+0.81 (0.16%)
After-hours: Apr 28, 2026, 7:37 PM EDT

Madrigal Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Market Capitalization
11,85313,2266,7304,5685,1791,449
Upgrade
Market Cap Growth
74.66%96.52%47.33%-11.79%257.45%-15.74%
Upgrade
Enterprise Value
11,21712,4625,8514,4525,0751,151
Upgrade
Last Close Price
516.69582.34308.57231.38290.2584.74
Upgrade
PS Ratio
12.3713.8037.36---
Upgrade
PB Ratio
19.5821.958.9211.2726.247.39
Upgrade
P/TBV Ratio
19.9122.228.9811.2726.247.39
Upgrade
EV/Sales Ratio
11.7013.0032.48---
Upgrade
Debt / Equity Ratio
0.580.580.160.290.250.00
Upgrade
Net Debt / Equity Ratio
-1.05-1.05-1.07-1.27-1.56-1.37
Upgrade
Net Debt / EBITDA Ratio
2.132.131.621.361.051.11
Upgrade
Net Debt / FCF Ratio
3.353.351.771.591.371.46
Upgrade
Asset Turnover
0.830.830.21---
Upgrade
Inventory Turnover
1.031.03----
Upgrade
Quick Ratio
3.603.605.795.353.103.52
Upgrade
Current Ratio
4.014.016.105.383.123.54
Upgrade
Return on Equity (ROE)
-42.49%-42.49%-80.35%-123.98%-150.12%-110.92%
Upgrade
Return on Assets (ROA)
-16.30%-16.30%-36.98%-47.41%-57.71%-54.09%
Upgrade
Return on Capital Employed (ROCE)
-31.60%-31.60%-57.00%-72.90%-119.00%-123.40%
Upgrade
Earnings Yield
-2.43%-2.18%-6.92%-8.18%-5.70%-16.69%
Upgrade
FCF Yield
-1.60%-1.44%-6.79%-7.13%-4.35%-12.71%
Upgrade
Buyback Yield / Dilution
-5.46%-5.46%-13.83%-9.05%-3.64%-7.05%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.